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Abstract 
Pediatric refractory epilepsy affects approximately 30% of all children diagnosed with epilepsy.  
Childhood refractory epilepsy patients pose a challenge for traditional approaches to epilepsy 
management due to their complex and unique needs.  Refractory epilepsy negatively impacts a patient’s 
ability to attend school or hold a job, and patients have a generally poor health status related to seizures as 
well as pharmaceutical side effects (Conway et al., 2016). The ketogenic diet (KD) is an alternative 
option for the treatment of pediatric refractory epilepsy due to established efficacy, manageable side 
effects, and reduced health care-associated costs due to reduced emergency department (ED) visits, and 
reduced inpatient admissions (Hallbook et al., 2015; Khoo et al., 2016; Lambrechts et al., 2017; Martin et 
al., 2016; Pasca et al., 2018; Whiting et al., 2017; Wijnen et al., 2017). When attempting to address the 
complex needs of a child with this chronic medical condition, interdisciplinary and multidisciplinary 
clinics have been shown to improve patient outcomes in various pediatric fields including refractory 
epilepsy, when compared to general, traditional clinics (Williams et al., 1995).  
 An interdisciplinary pediatric ketogenic diet clinic (KDC) was created in 2015 to provide a more 
coordinated approach to the management of pediatric refractory epilepsy patients on the KD. The clinic 
was staffed by a pediatric epileptologist, pediatric neurology nurse practitioner, registered dietician, and 
social worker. Through a retrospective design, data from pediatric KD patients were analyzed to 
determine the interdisciplinary KDC’s effects on seizure frequency, seizure related hospitalizations, 
number of seizure medications (AEDs), and adherence to the treatment regimen by both patients and 
providers when compared to the management of KD patients prior to implementation of the KDC, the 
traditional approach. The interdisciplinary approach to the KD yielded more seizure free patients, 
improved adherence to KD standards of care, reduced epilepsy related inpatient admissions, and 
demonstrated a greater number of patients experiencing a reduction in the number of AEDs when 
compared to the traditional approach.  
Keywords:  ketogenic diet, refractory epilepsy, child, pediatric, interdisciplinary clinic 
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Evaluation of an Interdisciplinary Ketogenic Diet Clinic for the Treatment of Pediatric Refractory 
Epilepsy 
Epilepsy affects up to 3% of the general population (Martin, Jackson, Levy, & Cooper, 2016). In 
children living in the United States, the prevalence is approximately 4.5 children for every 1,000 with an 
incidence of up to 82 cases/100,000 children per year (Camfield & Camfield, 2015). The most current 
definition of epilepsy, according to the International League against Epilepsy (ILAE), has recently been 
updated and defined as a disease diagnosed after a patient has experienced at least two seizures occurring 
at least 24-hours apart not contributed to a temporary cause (unprovoked) (Fisher et al., 2014). 
Additionally, the diagnosis is used to describe patients who have had one unprovoked seizure and a high 
probability of another unprovoked seizure in the future based on history or diagnostic testing.  
Furthermore, the definition also is applied to patients who have diagnostic testing revealing data 
associated with a specific epilepsy syndrome (Fisher et al., 2014). Traditionally, patients, including 
children, are treated with antiepileptic drugs (AEDs) first, before other treatment modalities are offered.  
The majority of patients will respond to the first appropriately chosen and dosed AED.  However, up to 
30% of children diagnosed with epilepsy will not respond to traditional AED treatment.  The patients who 
do not respond to at least two appropriately chosen and trialed AEDs are classified as having drug 
resistant, intractable, or refractory epilepsy (Bodin et al., 2016). It is important to offer these patients 
treatments and services which may be more beneficial than continued traditional, pharmaceutical 
treatments. 
Patients with refractory epilepsy have complex medical needs. Not only must seizures be 
managed with pharmaceutical treatments, but side-effects must be managed.  Additionally, epilepsy is 
commonly associated with other disorders and abnormalities, which must also be managed. Health related 
quality of life (HRQL) is known to be adversely affected in individuals with epilepsy.  Costs associated 
with treatment of refractory epilepsy increase as AEDs are added, side-effects are experienced, seizures 
continue, and the patient requires inpatient admissions and/or emergency department (ED) visits to 
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manage seizures. Adequate and appropriate treatment of children with epilepsy addresses both seizures as 
well as other medical and psychosocial aspects that are associated with the diagnosis (Lach et al., 2006). 
Refractory Epilepsy  
Uncontrolled, refractory epilepsy in children can have a catastrophic impact on a child’s life.  
Refractory epilepsy increases a patient’s seizure burden which includes, but is not limited to, seizure 
frequency, duration, and intensity.  Refractory epilepsy, in an otherwise healthy child, is associated with 
learning and cognitive difficulties (Mula & Cock, 2015). However, Mula and Cock (2015) speculate 
many children with refractory epilepsy have comorbidities also associated with such delays, precipitating 
a unique conundrum for providers. Not only does seizure burden impact cognition, learning, and speech, 
but it also has a dramatic impact on the patient’s and family’s quality of life. One controlled, experimental 
study published in 2003, suggests the QOL of epileptic children is poorer than reported in healthy 
children in both physical and psychosocial domains (Miller, Palermo, & Grewe, 2003).  Miller, Palermo, 
& Grewe go on to associate poorly controlled epilepsy and more AEDs with an inverse relationship to 
QOL scores (2003). Uncontrolled epilepsy places a burden on the patient and his or her family and 
community as medical treatments, procedures, hospital admissions, and costs are required throughout the 
patient’s lifespan. Along with the direct impact that the seizures themselves have, the outcomes of the 
disease impact a patient’s and family’s quality of life (QOL) (Talarska, 2007).   
Comorbidities associated with refractory epilepsy contribute to diminished QOL. In fact, Selassie 
et al., postulate comorbidities associated with epilepsy impact QOL more than seizures and AEDs (2014). 
Selassie (2014), noted comorbidities associated with people of all ages who had epilepsy and compared 
these prevalence rates to subjects who had migraines and to subjects who were healthy. Commonly 
associated comorbidities with epilepsy include, but are not limited to, stroke, migraine headaches, 
depression, anxiety, autism, and attention deficit disorder with hyperactivity (Selassie et al., 2014). 
Furthermore, comorbidities are predictive of poorer QOL reports, especially comorbidities associated 
with other neurologic abnormalities such as developmental delay, autism, or diminished cognitive 
abilities (Miller, Palermo, & Grewe, 2003). 
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Not only does seizure severity reduce QOL, but number of AEDs, caregiver unemployment, 
lower socioeconomic status, depression, anxiety, lower patient intelligence quotient (IQ) scores, and 
increased family demands also play a role (Conway et al., 2016). Compounding the issue with AEDs is 
the known issue of patients with refractory epilepsy not likely to respond to additional, traditional AEDs 
(Perry & Duchowny, 2013).  It is not uncommon for pediatric refractory epilepsy patients to be managed 
on 5 to 7 different AEDs, each with associated side effects.  Therefore, other treatment modalities have 
been implemented to reduce patients’ seizure burdens while simultaneously improving the patients’ QOL.  
Alternative treatment modalities include, but are not limited to, the ketogenic diet and other variations of 
the diet, implantation with a neurostimulator known as a vagus nerve stimulator (VNS), and resective 
epilepsy surgery.  However, these alternative treatment modalities are not suitable for every patient.  
Patients must be screened and assessed appropriately to ensure treatment recommendations will promote 
the best outcomes for each unique patient.  
The Ketogenic Diet 
 The KD is one of several types of dietary therapies utilized for the treatment of refractory 
epilepsy.  It is a high fat, very low carbohydrate diet, designed to alter the body’s energy source from the 
utilization of glucose to the utilization of fats.  The KD is prescribed as a ratio of grams of fats to grams 
of carbohydrates.  It can be utilized with traditional foods as well as specialty formulas. The metabolism 
of fats yields ketone bodies and a state of ketosis for the patient, measured with a serum beta 
hydroxybutyrate level.  It is not fully understood how the diet works.  Although, it has been theorized that 
ketones are neuroprotective, offering the patient an anticonvulsant effect as long as the patient remains in 
a state of adequate ketosis.  The KD has contraindications, is associated with side-effects, and must be 
strictly maintained for adequate benefit.  However, the diet has historically been shown to be effective in 
reducing seizure burden and enhancing quality of life for appropriately chosen refractory epilepsy patients 
(Lambrechts et al., 2017). 
 A recent review of the literature reveals at least 30% of all patients with all types of refractory 
epilepsy on the KD experienced at least a 50% reduction in seizure frequency from baseline (Hallbook et 
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al., 2015; Khoo et al., 2016; Lambrechts et al., 2017; Martin et al., 2016; Pasca et al., 2018).  Not unlike 
traditional, medical management, the patients studied on the KD also exhibited side-effects, with 
gastrointestinal side-effects most often reported.  Compliancy issues and discontinuation of the diet were 
noted in all studies, although listed as a primary outcome in the Wijnen et al. study from 2017.  
Ultimately, all patients with refractory epilepsy should be introduced to the KD as an option for treatment 
due to established efficacy with side effects monitored and health care associated costs likely reduced if 
inpatient initiation costs, ED visits, and inpatient admissions are reduced (Hallbook et al., 2015; Khoo et 
al., 2016; Lambrechts et al., 2017; Martin et al., 2016; Pasca et al., 2018; Whiting et al., 2017; Wijnen et 
al., 2017).  The unique and complex needs of pediatric refractory epilepsy patients necessitate a 
comprehensive and coordinated approach to optimize seizure treatments, specifically, the KD.  A team 
based, interdisciplinary approach to manage the KD as a treatment for pediatric refractory epilepsy offers 
patients and families the expertise and support to optimize medical management (Conway et al., 2016). 
Interdisciplinary and Multidisciplinary Clinics 
 Interdisciplinary clinics (IDC) and multi-disciplinary clinics (MDC) have demonstrated 
effectiveness in the management of complex health needs.  Each clinic approach brings together 
specialists in various fields to work together with the patient, who is central to the team. The goal of both 
approaches is to achieve better patient outcomes.  Although the terms are often used interchangeably, 
there are differences between the two approaches, as depicted in Figure 1.  An MDC involves a patient 
seeing various team members, in a separate and coordinated manner, with patients typically seeing all 
specialists involved in their care on the same day.  An IDC consists of one patient visit with all team 
members present in the same room, together with the patient, making treatment decisions (Korner, 2010). 
An IDC focuses on team work and collaboration to achieve optimal patient outcomes rather than the 
coordination of ideas and decisions (Korner, 2010).  In the MDC model, the providers are independently 
making decisions while communicating their decisions to other team members, often through a single 
coordinator. Team make-up may be directed by billing or the facility in which the team is functioning.  
For example, when billing Medicare for a multidisciplinary or interdisciplinary visit, the team must 
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include one physician, and a minimum of two other individuals from different disciplines, excluding 
nursing. Other multidisciplinary or interdisciplinary teams utilize a broader definition and include two or 
more health professionals from different disciplines who either diagnose, treat, manage, or support the 
patient (Parman, 2018). Although both IDCs and MDCs are used to manage complex health conditions 
and improve patient outcomes, the IDC approach may yield better efficacy due to a stronger emphasis on 
collaboration than MDCs (Korner, 2010). However, both approaches are known to produce better patient 
outcomes when compared to the traditional approach (Korner, 2010).   
There are more studies published about MDCs than IDCs.  MDCs have been reported in the 
management of pediatric asthma, neurocritical care follow-up, functional constipation, kidney disease, 
oncology, chronic headaches, Prader-Willi syndrome, and orthopedics (Ajarmeh et al., 2012; Cantrell & 
Rubel, 2011; Cook et al., 2017; Duis et al., 2019; Moe et al., 2016; Poenaru et al., 1997; Rabner et al, 
2015; Wainwright et al., 2014).  MDCs report better outcomes for patients with complex medical 
problems when compared to traditional approaches to patient management (Cook et al., 2017). Cook et 
al., assert an MDC is capable of adequately assessing and addressing complex modifiable issues in 
children (2017).  Many characteristics, such as depression, anxiety, seizure burden, and so forth, are noted 
to decrease a patient’s QOL and are considered modifiable factors associated with childhood refractory 
epilepsy.  Other MDCs have noted an improvement in patient satisfaction after implementing the clinics, 
compared to independent visits with each healthcare provider (Moe et al., 2016).  Still, other practices 
implementing MDCs note a reduction in gaps in care, specifically, a reduction in the number of required 
referrals and visits to other specialties (Williams, Kirby, & Piantino, 2017). When used with pediatric 
chronic kidney disease patients, an MDC led to increased medication adherence, improved disease 
progression, improved nutrition, and generally, improved outcomes (Ajarmeh, Er, Brin, Djurdjev, & 
Dionne, 2012).  
MDCs have been used in the treatment of complex pediatric neurologic issues as well.  For 
example, pediatric migraine patients were noted to have less school absences and higher functional 
performance after implementation of a pediatric headache MDC (Rabner, Gottlieb, Lazdowsky, & LeBel, 
INTERDISCIPLINARY KETOGENIC DIET CLINIC 8 
2015). Williams et al. reported outcomes associated with a pediatric refractory epilepsy clinic in 1995.  
The authors noted a higher success rate in reducing seizure frequency than was expected with a traditional 
approach.  QOL indicators were not specifically studied by Williams et al. (1995).  Reducing seizure 
frequency, however, is known to improve QOL in refractory epilepsy patients, as noted by Mula (2014). 
Furthermore, Williams et al., demonstrated patient and family satisfaction improved with a 
multidisciplinary team approach (1995).  MDCs are known to be the “gold standard” of care for pediatric 
neuromuscular diseases due to their ability to reduce barriers to providers and resources. Additionally, 
Paganoni et al., noted greater adherence to clinical practice guidelines, reduced hospital admissions, and 
improved patient advocacy with a pediatric neuromuscular MDC (2017).  Costs associated with the 
neuromuscular clinic, however, were high although the clinic was considered “cost-effective” (Paganoni 
et al., 2017). 
Pediatric refractory epilepsy is a complex medical condition with several treatment modalities. 
The KD is an effective treatment for these patients to decrease seizure burden (Hallbook et al., 2015; 
Khoo et al., 2016; Lambrechts et al., 2017; Martin et al., 2016; Pasca et al., 2018).  However, compliance 
and side-effects must be monitored and managed adequately (Wijnen et al., 2017).  MDCs and IDCs are 
known to promote positive outcomes when utilized to address complex medical diseases in other pediatric 
specialties (Ajarmeh et al., 2012; Cantrell & Rubel, 2011; Cook et al., 2017; Moe et al., 2016; Poenaru et 
al., 1997; Rabner et al, 2015; Wainwright et al., 2014). However, IDCs may foster more collaboration and 
team efficacy. Therefore, an interdisciplinary, pediatric, ketogenic diet clinic (KDC) can be utilized to 
deliver and manage care of pediatric refractory epilepsy patients initiating or maintaining the KD  
Theoretical Framework 
 A theory can help guide or validate the framework of a program in conjunction with evidenced 
based practices.  The Model for Effective Chronic Illness Care validates the creation of an 
interdisciplinary team (Wagner, Davis, Schaefer, & Von Korff, 2002). The Model for Effective Chronic 
Illness Care was first published in 1996 with an adaptation in 1999 and reprint in 2002 (Figure 2).  It 
attempts to describe how chronic illness can be best managed through a concerted effort between the 
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patient, provider(s), and the system (health care organization and community) (Wagner et al., 2002).  
Features of the model include practice change to accommodate the complex needs of patients with 
chronic medical conditions.  Additionally, patients are a key element and must be empowered to take an 
active role in the management of their healthcare needs.  Wagner et al. theorize encouraging self-
management can be accomplished through education and psychosocial support (2002).  The final two 
elements of the model note medical providers who must manage patients according to best practice, and 
information dissemination through reminders, feedback, and formal care planning.  The five key elements 
of the model are then organized into an interactive model where the health system consists of the practice 
providing appropriate clinic visits for which health professionals make research-based decisions and 
support their invested patients with information and resources available in the community.  Consequently, 
the model facilitates interactions between collaborative and informed health team members and an 
informed and proactive patient to achieve the best functional and clinical outcomes possible for a patient 
with a chronic illness (Wagner et al., 2002). The model’s collaborative, evidenced based management of 
care with a patient at its core confirms the need for an interdisciplinary clinic to best manage the complex 
health needs of a pediatric refractory epilepsy patient on the ketogenic diet. 
The Interdisciplinary Ketogenic Diet Clinic Design 
An interdisciplinary pediatric KDC was created in October, 2015 based on best practices and 
published experiences with IDCs and MDCs utilized in other specialty areas.  The KDC is within an 
outpatient child neurology clinic (CNC) in Louisville, Kentucky.  The outpatient clinic specializes in the 
care of patients with many neurologic conditions including, but not limited to, epilepsy, cerebral palsy, 
muscular dystrophy, autism, developmental delay, tuberous sclerosis, multiple sclerosis, 
neurodegenerative diseases, and migraines. The CNC employs multiple child neurologists, nurse 
practitioners, nurses, a social worker, and psychologist to care for the unique needs of pediatric neurology 
patients. Approximately 3000 unique pediatric patients with epilepsy are seen in the clinic each year, 
accounting for nearly 5000 outpatient appointments. Of these patients, approximately 900 have refractory 
epilepsy.  The CNC has a working relationship with the local children’s hospital.  The children’s hospital 
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has approximately 4000 admissions/year due to epilepsy, 1200 of which can be attributed to refractory 
epilepsy. Patients with refractory epilepsy are responsible for the majority of multiple admissions or 
readmissions secondary to seizures. Furthermore, the CNC collaborates with members of other disciplines 
from the local children’s hospital, such as dieticians and pharmacists. The KD has been a treatment 
modality offered jointly by the CNC and children’s hospital since prior to 2009. 
Prior to 2015, all patients on the KD returned to their primary neurology provider who managed 
all KD care. The independent manner in which providers managed KD care without use of an IDC, 
created situations where a KD patient may or may not have KD adjustments, adequate monitoring of side-
effects, or appropriate withdrawal of AEDs. Accompanying side effects and continued seizures could 
result in premature discontinuation of the diet, poor compliance, and increases in hospitalizations. With 
traditional care, outcomes and adherence to the KD recommendations could vary by provider.  However, 
recommended standard care for patients on the KD has remained consistent since 2009 at the CNC and 
includes follow-up appointments at the recommended intervals of 0-3-months post-diet initiation, 4-6-
months post-initiation, 7-9 months post-initiation, and 10-15-months post-initiation (Kossoff et al., 2018). 
Moreover, recommendations for ketogenic modifications, supplements, and laboratory testing have 
remained consistent, as well.  Since 2009, standard care at the CNC included AED levels and serum 
ketone levels (beta-hydroxybutyrate) drawn prior to every follow-up appointment. Therefore, 
implementation of the KDC resulted in no change to established standards of care, but altered the 
coordination and delivery of care.  
The interdisciplinary KDC is staffed by a team comprised of a primary neurologist responsible 
for AED adjustments, a dietician trained in the ketogenic diet and whom is responsible for making diet 
modifications, a social worker responsible for identifying needs and resources of the patient and family, 
and a pediatric neurology nurse practitioner responsible for managing both diet modifications and AED 
changes, as well as family education and communication. The purpose of this evaluation is to determine if 
participation in an interdisciplinary KDC yields improvements in epilepsy related outcomes of parent 
reported seizure frequency, inpatient hospitalizations, and the number of prescribed seizure medications, 
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as well as clinic outcomes of adherence by both patients and providers to the recommended treatment 
regimen (patient compliance) and discontinuation rates when compared to patients on the KD who 
received care as usual (no participation in an interdisciplinary clinic) .  
Methods 
 The interdisciplinary pediatric KDC was confirmed as best practice based on published 
experiences with IDCs and MDCs utilized in other specialty areas.  A literature review of IDCs and 
MDCs was conducted using EBSCOhost.  Within EBSCOhost, Academic Search Complete, CINAHL, 
and Medline, databases were utilized.  Search terms included “child”, “pediatric”, “refractory epilepsy”, 
“intractable epilepsy”, “multidisciplinary clinic”, and “interdisciplinary clinic”.  All articles utilized were 
in English.  Articles were not excluded based on date, with one article included, specific to pediatric 
refractory epilepsy, published in 1995. However, preference for inclusion in the literature review included 
dates after January 1, 2010. Identified outcomes were adapted from outcomes observed in the review of 
current literature based on refractory epilepsy treatment and outcomes observed in MDC/IDCs from other 
fields.  
Design 
The KD treatment option has been utilized since prior to 2009 with little variation to management.  
Recommended follow-up time intervals, laboratory testing, supplements, and methods of diet adjustments 
have remained consistent since this time. Therefore, the project’s primary design was conducted through a 
retrospective chart review, with data collection and analysis completed to compare outcomes of patients 
started on the KD prior to and after creation of the KDC for 4 outpatient visits or a maximum of 15-
months, beginning with the KD inpatient admission. When patients were initiated on the KD during the 
inpatient hospital admission, an order-set was used.  Therefore, all patients who had a KD initiation order-
set in the current electronic medical record (EMR) at the local children’s hospital were initially identified.  
The initial query identified 80 patients who had a KD initiation order-set from May, 2012 (start of current 
EMR, EPIC) through November, 2019. The initial inquiry of patients was cross referenced with the EMR 
from the CNC (Allscripts) and screened for inclusion criteria.  General inclusion criteria included patients 
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from birth to 18-years of age with a known diagnosis of refractory epilepsy (failure of two or more AEDs 
as determined by the patient’s primary neurology provider).  Additionally, inclusion criteria were set for 
each group.  The pre-intervention group included children who had at least one documented outpatient 
neurology follow-up after initiation of the KD and who were initiated on the diet from May, 2012 through 
October, 2014 with all outpatient visits occurring prior to creation of the KDC. The post-intervention 
group included children who had at least one outpatient visit with the KDC and were initiated on the diet 
beginning in October, 2015 through May, 2018 with all outpatient KD visits occurring within the KDC. 
Ultimately, 20 patients met all inclusion criteria with 30 patients excluded due to lack of follow-up care, 
discontinuation of the KD prior to follow-up appointments, follow-up visits occurred prior to and within 
the KDC, or the patient had not completed 4 outpatient visits or 15-months of treatment on the KD. Study 
data were collected and managed using REDCap electronic data capture tools hosted at The University of 
Louisville (Harris et al., 2009). REDCap (Research Electronic Data Capture) is a secure, web-based 
software platform designed to support data capture for research studies, providing 1) an intuitive interface 
for validated data capture; 2) audit trails for tracking data manipulation and export procedures; 3) 
automated export procedures for seamless data downloads to common statistical packages; and 4) 
procedures for data integration and interoperability with external sources. 
Outcomes and Analysis 
 Data were evaluated by comparing outcomes in the pre-intervention group to outcomes in the 
post-intervention group. SPSS software was used for descriptive statistics and statistical analyses. The 
evaluation utilized descriptive data to determine information about patient demographics (age, gender, 
and race), as well as types of epilepsy (focal, generalized, or multi-focal), MRI results (lesion identified or 
no lesion identified), and insurance provider (private or Medicaid).  Additionally, descriptive data were 
collected and reported regarding the number of AEDs the patient was taking at the time of diet initiation.  
Epilepsy Related Outcomes 
 Epilepsy related outcomes included seizure frequency, number of AEDs, and the number of 
epilepsy related inpatient admissions (as noted in the history and physical, consultation note, or daily 
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progress notes), as noted in Table 1. Seizure frequency was defined as status epilepticus, daily seizures, 
weekly seizures, monthly seizures, < monthly seizures, and no seizures. Descriptive statistics were used 
to compare seizure frequency and number of AEDs at recommended follow-up appointment interval 
encounters. Analysis included available data with patients at each interval with missing data being 
omitted case-wise. Consequently, the sample size fluctuated at each encounter interval. Descriptive 
statistics were also used to compare the number of epilepsy-related inpatient admissions occurring within 
the study period for both groups. Additionally, the number of patients who experienced reductions in 
seizure frequency and AEDs as well as the number of patients who experienced inpatient admissions were 
analyzed utilizing a 2-sided Fishers Exact Tests.  
Clinic Outcomes 
 Patient compliance, adherence to recommended KD follow-up intervals, and discontinuation rates 
were analyzed to compare process and guidelines outcomes both pre-implementation and post-
implementation of the KDC (Table 1). Patient compliance was defined as; patients with no more than one 
“no show”, serum beta-hydroxybutyrate (BOH) levels ³ 2mmol/L, and therapeutic AED levels. Data were 
collected at each follow-up appointment, but reported once, at the end of the 15-month data collection for 
all study participants. Follow-up schedule adherence, patient compliance, and number of discontinuations 
were analyzed with 2-sided Fisher’s Exact Tests to determine if there was an association between clinical 
outcomes and care model.  
Results 
 Twenty patients were included in the evaluation (N = 20).  Seven patients were included in the 
pre-intervention group (n = 7) and 13 patients were included in the post-intervention group (n = 13).  
Demographics of the samples are noted in Table 2. The majority of patients in the pre-intervention group 
were female (57.1%) compared to a majority of males in the post-intervention group (61.5%). The mean 
age of the patients included in the pre-intervention group was 1.72 years (SD = 1.52) compared to 6.56 
years (SD = 5.80) in the post-intervention group.  The predominant race and ethnicity of both groups was 
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white, Caucasian.  Patients on Medicaid accounted for 42.9% of the pre-intervention group and 84.6% 
(11) of the post-intervention group.  The remaining patients in each group had private insurance.  
Additionally, epilepsy characteristics were identified for each group (Table 3).  Focal epilepsy 
was the most frequent type of epilepsy in both groups (42.9% in in pre-intervention and 38.5% in the 
post-intervention group). Furthermore, 28.6% of the pre-intervention group exhibited generalized 
epilepsy and 28.6% of patients exhibited multifocal epilepsy.  Generalized, multi- focal, and focal 
epilepsy were almost equally represented in the post-intervention group, with 30.8%, 30.8%, and 38.5%, 
respectively.  MRI findings were different between the 2 groups with brain lesions identified in 28.6% of 
patients in the pre-intervention group and 69.2% of patients in the post-intervention group.  
Lastly, the number of AEDs and seizure frequency at the time of KD initiation were identified for 
the 2 groups (Table 3). In both groups, daily seizures was the most common frequency with 71.4% (5) of 
the pre-intervention group and 53.8% in the post-intervention group.  There were 3 (23.1%) KD 
initiations for refractory status epilepticus in the post-intervention group and none noted in the pre-
intervention group, although there was no significant association between status epilepticus and care 
model when analyzed with a 2-sided Fisher’s Exact Test (n = 20), p = .52.  One patient in the post-
intervention group had no reported seizures at the time of initiation.  The average number of AEDs was 
greater in the post-intervention group (M = 3.38, SD = 1.50) compared to the pre-intervention group (M = 
2.71, SD = 1.38). 
Epilepsy Related Outcomes 
 Epilepsy related outcomes were analyzed in both groups with number of AEDs and seizure 
frequency analyzed at each follow-up appointment interval.  Although the initial sample size at KD 
initiation was 7 in the pre-intervention group and 13 in the post-intervention group, sample sizes 
fluctuated at each follow-up interval. Seizure frequency was documented at each recommended follow-up 
interval based on parental report.  Figure 3 and Table 4 demonstrate that both care model groups included 
patients who achieved seizure freedom. The first follow-up appointment included 3 patients from each 
group who achieved seizure freedom.  At the time of the fourth follow-up appointment, the post-
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intervention group was the only group noted to have patients who had achieved seizure freedom. The 
number of patients exhibiting daily, weekly, monthly, and less than monthly seizures fluctuated 
throughout the 15-months of data collection.  However, all follow-up appointments included patients 
experiencing a reduction in seizure frequency as depicted in Figure 4. The percent of patients 
experiencing a decrease in seizure frequency ranged from 50% - 66.7% in the pre-intervention group and 
22.22% - 63.64% in the post-intervention group, with the exclusion of the patient who initiated the diet 
without current seizures. A 2-sided Fisher’s Exact Test showed no significant associations between the 
number of patients experiencing a reduction in seizure frequency and the care model at the first follow-up 
interval (n = 17), p = .16, the second follow-up interval (n = 16), p = 1, the third follow-up interval (n = 
12) p = .236, or the fourth follow-up interval (n = 12), p = 1. 
 The number of AEDs changed throughout the 15-month period for both groups as noted in Table 
5 and Figure 5.  Both groups experienced a reduction in AEDs at the first follow-up appointment with the 
pre-intervention taking a mean of 2.17 (SD = 1.38) AEDs and the post-intervention group taking 3.38 (SD 
= 1.50) AEDs.  The percent of patients able to decrease the number of AEDs at a follow-up encounter 
ranged from 16.7% - 40% in the pre-intervention group and 33% - 50% in the post-intervention group as 
noted in Figure 6. Utilizing a 2-sided Fisher’s Exact Test, no significant associations were found between 
the number of patients experiencing a reduction in AEDs and the care model at the first follow-up interval 
(n = 17), p = .33, the second follow-up interval (n = 16, p = 1), the third follow-up interval (n = 12), p = 1, 
or the fourth follow-up interval (n = 12), p = .58. 
 Lastly, the number of epilepsy-related inpatient admissions were analyzed for both groups.  The 
pre-intervention group had a mean of 1.71 (SD = 2.56) admissions per patient for the 15-months of data 
collection.  The post-intervention group had a mean of 0.54 (SD = 0.66) admissions per patient. The pre-
intervention group had 57% of patients admitted and the post-intervention group had 38% of patients 
admitted in 15-months. Utilizing a 2-sided Fisher’s Exact Test, no significant association was found 
between the number of patients requiring an epilepsy related admission and the care model (n = 20), p 
= .64. 
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 Clinic Outcomes 
 Patient compliance is a multi-faceted outcome looking at “no show” rates as well as therapeutic 
levels of drugs and serum ketones (beta-hydroxybutyrate).  There were no “no shows” in the pre-
intervention group, and two (15.4%) in the post-intervention group. A 2-sided Fisher’s Exact Test 
indicated no significant association between “no shows” and the care model, (n = 20), p = .52. Serum 
BOH levels ³ 2mmol/L indicate a patient is in adequate ketosis.  Four patients (57.14%) in the pre-
intervention group had a total of five BOH levels drawn and monitored within the 15 months studied, of 
which, four (80%) were therapeutic.  The post-intervention group included 10 patients (76.92%) who had 
a total of 33, BOH levels drawn and monitored, of which 24 (72.73%), were therapeutic. A 2-sided 
Fisher’s Exact Test indicated no significant association between BOH levels ³ 2mmol/L and care model, 
(n = 38), p = 1. Likewise, therapeutic AED levels can indicate if a patient is taking his or her medications. 
AED levels were drawn seven times, within the 15-months for three patients (42.86%) in the pre-
intervention group with three (42.86%) levels noted to be therapeutic. Six patients in the post-intervention 
group had AED levels drawn a total of 25 times within the 15-months, of which 18 (72%) were 
therapeutic.  A 2-sided Fisher’s Exact Test indicated no significant association between number of 
therapeutic AED levels and study group, (n = 32), p = .19. 
 Adherence to the recommended follow-up schedule and discontinuation rates were also analyzed 
to determine alterations based on care model.  Four patients (57.1%) adhered to the entire follow-up 
schedule in the pre-intervention group six patients (46.2%) in the post-intervention group.  A 2-sided 
Fisher’s Exact Test indicated no significant association between adherence to the entire recommended 
follow-up schedule and study group, (N = 20), p = 1. Finally, discontinuation rates were noted during the 
15-month study period.  Two patients (28.6%) in the pre-intervention group discontinued the diet within 
15-months while three (23.1%) discontinued the diet in the post-intervention group.  Again, a 2-sided 
Fisher’s Exact Test indicated no significant association between discontinuing the diet and study group, 
(N = 20), p = 1. Discontinuation reasons cited in the pre-intervention group included side-effects (1) and 
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lack of efficacy (1).  One patient in the post-intervention group discontinued the KD due to side effects, 
another due to parental choice, and a third patient discontinued for unknown reasons. 
Discussion 
 Analysis of the interdisciplinary KDC is an evaluation of a program created in October, 2015.  
However, outcomes of the program had not been analyzed.  Due to a lack of benchmarks, data from the 
KDC were compared to data from similar patients who did not participate in the interdisciplinary clinic.  
The sample size was 20, limiting statistical analysis.  However, by comparing raw data and non-
parametric tests, the outcomes of the KDC can still useful when trying to translate the utilization and 
benefits of an IDC for the treatment of pediatric refractory epilepsy with the KD. 
 All patients included in the study had a diagnosis of refractory epilepsy, although one patient was 
seizure free at the time of KD initiation.  Parents of this seizure free patient elected to start the diet due to 
the patient’s regimen of multiple AEDs with prior seizures occurring over one-year before the KD was 
initiated.  Other similar features between the 2 groups included the type of epilepsy treated.  Both groups 
were predominantly composed of children with focal epilepsies.  However, the majority of the post-
intervention group had an identifiable brain lesion, presumably contributing to their epilepsy.  Gender 
differences between the two groups were similar. Conversely, the post-intervention group was older than 
the pre-intervention group by nearly 5-years.  After the start of the KDC, most patients initiated on the 
diet had Medicaid, in contrast to those started on the KD prior to the KDC.  Only 2% of the post-
intervention group was African-American, while the pre-intervention group was comprised fully of 
Caucasians.  More striking dissimilarities between the two groups were noted with the number of AEDs 
and seizure frequency. The post-intervention group had harder to control epilepsies as noted by three diet 
initiations for status epilepticus, although this was not significant, statistically. Furthermore, the post-
intervention group was on more AEDs at the time of diet initiation compared to the pre-intervention 
group, although it is important to note, means were not statistically compared due to the small sample 
size.  The post-intervention group was noted to have more identified MRI lesions and an older average 
age than the pre-intervention group, possibly affecting seizure severity and etiology. Although statistical 
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significance was not established with study group comparisons of demographics, nearly twice as many 
KD initiations took place after the start of the interdisciplinary KDC as they did prior to its development.  
This could be due to more knowledge about the KD among neurology providers as well as a more 
concerted effort to consider the diet for all pediatric refractory epilepsy patients. 
Epilepsy Related Outcomes 
 The ketogenic diet is an efficacious treatment for refractory epilepsy.  Efficacy in epilepsy 
treatment is often noted by reporting seizure frequency, number of AEDs, and QOL.  This evaluation 
analyzed both seizure frequency and number of AEDs, which are inversely related to QOL. Both groups 
exhibited patients with a reduced seizure frequency at each encounter.  Again, although statistical 
significance was not established, the post-intervention group produced five seizure free patients at the 4-
6-month encounter and maintained at least two seizure free patients through the 15-month study, 
including the patient who had rare seizures at the time of KD initiation.  The pre-intervention group 
produced seizure freedom in a maximum of three patients at the first follow-up interval, but this was not 
sustained and ultimately, no patients in the pre-intervention group remained seizure free at the last follow-
up appointment.  Due to the inverse relationship of seizure frequency and QOL, the KDC group may have 
experienced an increase in QOL compared to the pre-intervention group. In both groups, patients 
exhibiting daily seizures did not experience a dramatic reduction in seizure frequency with the pre-
intervention group decreasing from four to two patients, and the post-intervention group decreasing from 
seven to five.  However, the majority of parents in this group expressed satisfaction with the KD due to 
improvements in cognition and/or development, as noted in the EMR. The difference in percent of 
patients from each group who experienced a reduction in seizures was not statistically significant, 
although the pre-intervention group had a minimum of 50% of patients experience a seizure frequency 
reduction, compared to 22.22% minimum noted in the post-intervention group.  Reduction in seizure 
frequency is congruent with established KD seizure reduction rates (Hallbook et al., 2015; Khoo et al., 
2016; Lambrechts et al., 2017; Martin et al., 2016; Pasca et al., 2018).  However, it is important to note 
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the post-intervention group may have had more difficult to control seizures as evidenced by seizure 
frequency and noted number of AEDs at the time of KD initiation. 
 Moreover, both groups experienced reductions in number of AEDs at the first and second follow-
up appointments. But, the post-intervention group concluded the study on a greater number of AEDs than 
at initiation. The number of patients, however, in the post-intervention group who were able to reduce 
their AEDs was greater than those in the pre-intervention group, although this was not statistically 
significant.  Again, QOL is inversely related to number of AEDs, although this was not explicitly 
analyzed. While 50% of the patients participating in the KDC experienced a reduction in numbers of 
AEDs, the remaining patients may have had additional AEDs added to their treatment regimen.   
 Finally, patients participating in the KDC were less likely to be admitted to the hospital, although 
this was not statistically significant.  Patients in the pre-intervention group had nearly three times as many 
admissions per patient as the patients in the post-intervention group. Although patients participating in the 
KDC tended to be on more AEDS, they had fewer epilepsy related hospital admissions. 
Clinic Outcomes 
 “No Shows” were a significant problem among all outpatient appointments in the CNC.  Typical 
“no show” rates in the general clinic were approximately 20% during the study period (A. Jennings, 
personal communication, February 26, 2020). There were no “no shows” documented in the pre-
intervention group. Conversely, there were two in the KDC group, accounting for 15.4% of the sample, 
although not statistically significant.  The “no show” rate in the KDC is, therefore, lower than the current 
general neurology clinic.  
 In addition to “no show” rates, it is important to note if standards of care were appropriately 
delivered in both groups. The full, recommended follow-up schedule was followed more consistently in 
the pre-intervention group compared to the post-intervention group, although this was not statistically 
significant. Possible causes of the discrepancy may be related to available KDC appointments.  When the 
KDC was initiated, the clinic was held for one, half-day, each month for a total of four KDC 
appointments, per month.  In 2016, the KDC days increased to two, half-days, each month for a total of 
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eight KDC appointments, per month. All appointments were full during KDC days with exception of late 
cancelations or “no shows”.  Therefore, it is possible that patients were unable to be seen for a 
recommended follow-up appointment at the recommended interval due to lack of availability.   
 Monitoring therapeutic levels of BOH and AEDs is another vital component in the management 
and monitoring of patients on the KD.  Standard of care recommends levels to be monitored before each 
scheduled appointment.  Not only must BOH and AED levels be ordered appropriately by the provider, 
but they also require patient and family compliance to ensure they are obtained as ordered.  Furthermore, 
therapeutic BOH and AED levels indicate optimal management of both the KD and AEDs.  BOH levels 
were drawn more often and in proportionately more patients in the post-intervention group, compared to 
the pre-intervention group, although this was not statistically significant.  However, it was clinically 
significant, allowing optimization of KD management when this occurred. Conversely, therapeutic BOH 
levels were noted more often in the pre-intervention group.  It is important to note the pre-intervention 
group included only five, BOH levels in four patients, whereas the post-intervention group included 33 
levels in 10 patients. Similarly, to BOH levels, AED levels were drawn more often and in proportionately 
more patients in the post-intervention group compared to the pre-intervention group.  Again, this 
association was not statistically significant.  Contrary to the BOH levels, AED levels were more often 
therapeutic in the post-intervention group compared to the pre-intervention group. BOH and AED levels 
were obtained more appropriately in the post-intervention group, compared to the pre-intervention group 
with therapeutic AED levels noted more often in the post-intervention group, but therapeutic BOH levels 
noted more often in the pre-intervention group.  
 Finally, discontinuation rates were analyzed to determine if there were any differences between 
the two groups. Discontinuation rates of the KD within the 15-months of data collection were similar 
between the two groups.  However, discontinuation due to lack of efficacy was noted only in the pre-
intervention group, with one patient.  Discontinuation of the KD due to side effects was noted in both 
groups. Therefore, participation in the interdisciplinary KDC did not appear to affect discontinuation rates 
when compared to the pre-intervention group. 
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Limitations 
 The retrospective design of the evaluation created significant limitations.  First, only patients 
established on the diet in the past were utilized, limiting the sample size.  Parametric analysis was not 
possible due to this small sample size.  Furthermore, the small sample size limited statistical significance 
with non-parametric analysis, as well.  The sample size was reduced further as patients had missing data 
for some follow-up appointments. Furthermore, in prior studies patient and family satisfaction improved 
in MDCs and IDCs (Moe et al., 2016; Williams et al., 1995). The retrospective design did not allow for 
the collection of information regarding patient, family, or team member satisfaction, although, it is 
important to note all original members of the CNC KDC anecdotally expressed high satisfaction with the 
KDC. Data were collected from chart-reviews within two EMR systems and documented by different 
providers.  Furthermore, different providers were responsible for establishing refractory epilepsy as the 
patient’s diagnosis creating possible inaccuracies. Lastly, cost-effectiveness or actual costs of the KDC 
were not analyzed.  However, with the decrease in inpatient admissions and large number of patients 
reducing their number of AEDs in the KDC group, the financial burden of epilepsy may be reduced on 
the patient, family, and healthcare system, overall when utilizing an IDC approach. Likewise, QOL scores 
were not assessed.  However, with the established inverse relationship of seizure frequency and number 
of AEDs with QOL, the positive effect of the KDC on QOL can be inferred.  
Conclusion 
 Childhood refractory epilepsy may affect up to 30% of all children diagnosed with epilepsy.  The 
diagnosis can be devastating for the child and family.  Traditional medical management is widely known 
to be grossly ineffective at treating epilepsy once a patient has failed two appropriately trialed and chosen 
AEDs.  Furthermore, the patient will experience side-effects, sometimes debilitating, with each 
medication added to the regimen. Therefore, it is vital to be able to offer efficient and effective, 
coordinated care capable of offering an alternative treatment to these patients.  The KD is a safe and 
effective treatment for refractory epilepsy.   
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 Several treatment outcomes of pediatric refractory epilepsy patients on the KD can be optimized 
with an interdisciplinary team that includes both the patient and family.  The interdisciplinary KDC at a 
local CNC utilized a coordinated care approach where the patient and family interacted with the primary 
neurologist, a dietician trained in the ketogenic diet and other dietary approaches, a social worker capable 
of identifying needs and resources of the patient and family, and a pediatric neurology nurse practitioner 
capable of managing diet modifications, AED changes, and family education. The interdisciplinary 
approach aided in the facilitation of the patient through the KD program, offering the patient and family 
vital information and education about the KD.  Although not statistically significant, epilepsy 
management through the interdisciplinary KDC yielded more patients becoming and remaining seizure 
free, improved adherence to KD standards of care, reduced the number of epilepsy related inpatient 
admissions, and allowed more patients to reduce their number of AEDs when compared to the traditional 
approach.  
 In the future, prospective studies should be conducted with a larger, multicenter sample to better 
determine statistical significance of an IDC approach to management of children on the KD.  Patients 
include in future studies should be determined to have refractory epilepsy based on continued seizures 
despite failure of appropriate AEDS, reducing potential for bias and inaccurate diagnoses. Furthermore, 
consistent approaches to KD patient management noted within a KDC may better yield the ability for 
prospective, randomized controlled trials to be performed and assist with future ketogenic diet and 
epilepsy developments, compared to the traditional approach. Patient, family, and team member 
satisfaction should be analyzed in addition to changes in QOL through valid and reliable satisfaction and 
QOL tools. Additionally, costs associated with an interdisciplinary KDC should be performed. Data from 
this interdisciplinary clinic and future studies may ultimately be adapted for use to support the creation of 
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Tables 
Table 1 
Interdisciplinary Ketogenic Diet Clinic Evaluation Outcomes 
Epilepsy Related Outcomes Definition 






Number of AEDs  
Number of Epilepsy Related Admissions Number of admissions during timeframe 
 
Clinic Related Outcomes Definition 
Patient Compliance: 
“No Show” rate 
Therapeutic Serum Beta-
Hydroxybutyrate Levels 







More than one “no show” 
serum beta-hydroxybutyrate (BOH) levels ³ 
2mmol/L 
Therapeutic as determined by lab 
 
Number of patients discontinuing the diet in 
timeframe 
Entire recommended follow-up schedule followed 
(yes or no) 
Note. Antiepileptic Drugs (AEDs) 
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Table 2 
Patient Demographics  
 
Pre-Intervention (n = 7) Post-Intervention (n = 13) 
Mean age at initiation years (SD) 1.72 (1.52) 6.56 (5.8) 
Gender 
  
 % Female (n) 57.1% (4) 38.5% (5) 
% Male (n) 42.9% (3) 61.5% (8) 
Race 
  
% White (n) 100% (7) 84.6% (11) 
% African-American (n) 0% (0) 15.4% (2) 
Insurance 
  
% Medicaid (n) 42.9% (3) 84.6% (11) 
% Private (n) 57.1% (4) 15.4% (2) 
Note. N = 20 
  
INTERDISCIPLINARY KETOGENIC DIET CLINIC 29 
Table 3 
Patient Epilepsy Characteristics  
 
Pre-Intervention (n = 7) Post-Intervention (n = 13) 
Type of Epilepsy   
 % Generalized (n) 28.6% (2) 30.8% (4) 
% Focal (n) 42.9% (3) 38.5% (5) 
% Multifocal (n) 28.6% (2) 30.8% (4) 
Lesion identified on MRI   
% Yes (n) 28.6% (2) 69.2% (9) 
% No (n) 71.4% (5) 30.8% (4) 
Mean Number of AEDs (SD) 2.71 (1.38) 3.38 (1.5) 
Seizure Frequency   
% None 0% (0) 7.7% (1) 
% < Monthly 0% (0) 7.7% (1) 
% Monthly 14.3% (1) 0% (0) 
% Weekly 14.3% (1) 7.7% (1) 
% Daily 71.4% (5) 53.8% (7) 
% Status 0% (0) 23.1% (3) 
Note.  N = 20; Antiepileptic Drugs (AEDs) 
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Table 4 

























None 0 1  3 3  1 5  1 2  0 2 
< 









monthly 1 0  0 0  1 0  0 0  0 1 
Weekly 1 1  0 0  1 3  0 2  0 0 
Daily 5 7  2 8  2 3  1 5  2 5 
Status 0 3  0 0  0 0  0 0  0 0 
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Table 5 
Average (M) Number of Antiepileptic Drugs (AEDs) per Patient 
Visit 
Pre-Intervention  







Initial 2.714 (1.38) 7 3.385 (1.5) 13 
0-3 months 2.167 (1.17) 5 3.09 (1.45) 11 
4-6months 1.8 (1.3) 5 2.91 (1.58) 11 
7-9 months 2.67 (2.08) 3 3.55 (1.51) 9 
10-15months 2.67 (2.06) 4 3.75 (1.98) 8 
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Figures 
Figure 1 
Graphic representation of an Interdisciplinary Clinic (IDC) versus a Multidisciplinary Clinic (MDC) 
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Figure 2 














Note. Adapted from 2002 Wagner, E. H., Davis, C., Schaefer, J., Von Korff, M., & Austin, B. (2002). A 
survey of leading chronic disease management programs: Are they consistent with the literature? Journal 
of Nursing Care Quality, 16(2), 67–80. 
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Figure 3 
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Figure 4 
Percent of Patients Experiencing Reduction in Seizure Frequency  
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Figure 5 
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Figure 6 
Percent of Patients Experiencing a Reduction in AEDs at each Recommended Follow-up Interval 
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